Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Reckitt Benckiser buys back narcotic addition drug rights from Merck for $153 million
Yahoo/AP
Sunday, March 21, 2010 - 9:21am
tags:
Reckitt Benckiser, Merck, narcotics, Suboxone, Subutex, Temgesic
Why Pfizer's Better Off Without Ratiopharm
Motley Fool
Saturday, March 20, 2010 - 11:42am
tags:
Pfizer, Ratiopharm, Teva Pharmaceuticals, M&A
Medtronic Wins Backing for First MRI-Safe Pacemaker
Bloomberg
Saturday, March 20, 2010 - 11:41am
tags:
pacemakers, Medtronic
How AstraZeneca Is Turning the Tide in Its Legal War Over Antipsychotic Drugs
BNET Pharma
Saturday, March 20, 2010 - 11:40am
tags:
AstraZeneca, lawsuits, Seroquel, antipsychotics
The Rush To Buy ImmunoGen
Seeking Alpha
Saturday, March 20, 2010 - 11:38am
tags:
Immunogen
Why Doing Something About ‘Pay for Delay’ Will Have to Wait
WSJ Online
Saturday, March 20, 2010 - 11:37am
tags:
pay-for-delay, healthcare reform
Medicines Co. says patent extension denied
Marketwatch
Saturday, March 20, 2010 - 11:35am
tags:
Medicines Company, patents, blood thinners, Angiomax
Glaxo's Asthma Drug Looks Increasingly Bullet-Proof
Seeking Alpha
Saturday, March 20, 2010 - 11:34am
tags:
GSK, asthma, Vectura, Sandoz, generics, Advair
FDA warns Zocor, Vytorin raise muscle injury risk
Marketwatch
Saturday, March 20, 2010 - 11:32am
tags:
FDA, Zocor, Vytorin, Merck
Roche CEO Schwan Puts Science First in Pursuing Deals
Businessweek
Friday, March 19, 2010 - 10:50am
tags:
Roche, Pharma CEOs, Severin Schwan, M&A
A.P. Pharma nausea drug hit with FDA rejection
Fierce Biotech
Friday, March 19, 2010 - 10:48am
tags:
FDA, AP Pharma
Astellas Pharma meets antitrust condition in takeover attempt of OSI Pharmaceuticals
Yahoo/AP
Friday, March 19, 2010 - 10:33am
tags:
Astellas, OSI Pharmaceuticals, M&A
OSI reports European recommendation on Tarceva
Yahoo/AP
Friday, March 19, 2010 - 10:23am
tags:
OSI Pharmaceuticals, Europe, Tarceva, lung cancer
Judge gives Medicines Co. another chance
Fierce Pharma
Friday, March 19, 2010 - 10:09am
tags:
Medicines Company, Angiomax
Valeant to Acquire Branded Generics/OTC Company in Brazil
Yahoo
Friday, March 19, 2010 - 9:57am
tags:
generics, M&A, Valeant Pharmaceuticals, Brazil, OTC
PhRMA Annual Meeting: Things Really Have Changed
InVivo
Friday, March 19, 2010 - 9:05am
tags:
PhRMA
What to Expect for Biotech Stocks
Minyanville
Friday, March 19, 2010 - 9:03am
tags:
biotech, Cell Therapeutics, Somaxon, Dendreon, Allos, GenVec, Arena Pharmaceuticals, Vivus
Novelos cancels lung-cancer drug project
Bizjournals.com
Friday, March 19, 2010 - 8:59am
tags:
Novelos Therapeutics, lung cancer
Democrats Gain Support as They Move Toward Health-Vote Showdown
Bloomberg
Friday, March 19, 2010 - 8:52am
tags:
healthcare bill, healthcare reform
Diabetes Drug Supporters Had Financial Tie to Glaxo, Study Says
Bloomberg
Friday, March 19, 2010 - 8:33am
tags:
GSK, diabetes, physicians, Avandia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.